Celldex Therapeutics, Inc. Operating Cash Flow
Celldex Therapeutics, Inc. (CLDX) reported Operating Cash Flow of -$123.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$57.41M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$65.59M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$63.94M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$48.63M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$210.94M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$157.78M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$107.29M.
- Celldex Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$103.73M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$57.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$123.00M 10-Q · filed 2026-08-06 | -$186.94M derived: sum of 3 quarters · filed 2026-08-06 | -$235.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$65.59M 10-Q · filed 2026-05-07 | -$129.53M derived: sum of 2 quarters · filed 2026-05-07 | -$178.16M derived: sum of 3 quarters · filed 2026-05-07 | -$222.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$63.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$112.57M derived: sum of 2 quarters · filed 2026-02-25 | -$156.57M derived: sum of 3 quarters · filed 2026-08-06 | -$210.94M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$48.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$92.63M derived: sum of 2 quarters · filed 2026-08-06 | -$147.00M 10-Q · filed 2025-11-10 | -$179.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$44.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$98.38M 10-Q · filed 2026-08-06 | -$130.85M derived: sum of 3 quarters · filed 2026-08-06 | -$186.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$54.37M 10-Q · filed 2026-05-07 | -$86.85M derived: sum of 2 quarters · filed 2026-05-07 | -$142.19M derived: sum of 3 quarters · filed 2026-05-07 | -$171.51M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$32.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$87.81M derived: sum of 2 quarters · filed 2026-02-25 | -$117.14M derived: sum of 3 quarters · filed 2026-02-25 | -$157.78M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$55.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$84.66M derived: sum of 2 quarters · filed 2025-11-10 | -$125.30M 10-Q · filed 2025-11-10 | -$157.84M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$29.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$69.97M 10-Q · filed 2025-08-07 | -$102.50M derived: sum of 3 quarters · filed 2026-02-25 | -$121.49M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$40.64M 10-Q · filed 2025-05-08 | -$73.17M derived: sum of 2 quarters · filed 2026-02-25 | -$92.16M derived: sum of 3 quarters · filed 2026-02-25 | -$119.36M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$32.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$51.53M derived: sum of 2 quarters · filed 2026-02-25 | -$78.72M derived: sum of 3 quarters · filed 2026-02-25 | -$107.29M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$18.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$46.19M derived: sum of 2 quarters · filed 2024-11-06 | -$74.76M 10-Q · filed 2024-11-06 | -$96.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$27.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$55.77M 10-Q · filed 2024-08-08 | -$77.53M derived: sum of 3 quarters · filed 2025-02-27 | -$112.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$28.57M 10-Q · filed 2024-05-06 | -$50.33M derived: sum of 2 quarters · filed 2025-02-27 | -$85.52M derived: sum of 3 quarters · filed 2025-02-27 | -$107.77M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$21.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$56.95M derived: sum of 2 quarters · filed 2025-02-27 | -$79.20M derived: sum of 3 quarters · filed 2025-02-27 | -$103.73M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$35.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$57.44M derived: sum of 2 quarters · filed 2023-11-02 | -$81.97M 10-Q · filed 2023-11-02 | -$96.49M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$22.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$46.78M 10-Q · filed 2023-08-08 | -$61.30M derived: sum of 3 quarters · filed 2024-02-26 | -$77.67M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$24.53M 10-Q · filed 2023-05-04 | -$39.06M derived: sum of 2 quarters · filed 2024-02-26 | -$55.43M derived: sum of 3 quarters · filed 2024-02-26 | -$67.36M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$14.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$30.89M derived: sum of 2 quarters · filed 2024-02-26 | -$42.83M derived: sum of 3 quarters · filed 2024-02-26 | -$60.91M 10-K · filed 2024-02-26 |
| 2021-09-30 | -$16.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$28.30M derived: sum of 2 quarters · filed 2022-11-09 | -$46.39M 10-Q · filed 2022-11-09 | -$51.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$11.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$30.01M 10-Q · filed 2022-08-08 | -$35.23M derived: sum of 3 quarters · filed 2023-02-28 | -$47.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$18.08M 10-Q · filed 2022-05-05 | -$23.30M derived: sum of 2 quarters · filed 2023-02-28 | -$35.16M derived: sum of 3 quarters · filed 2023-02-28 | -$46.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$17.07M derived: sum of 2 quarters · filed 2023-02-28 | -$28.29M derived: sum of 3 quarters · filed 2023-02-28 | -$40.40M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$11.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$23.08M derived: sum of 2 quarters · filed 2021-11-09 | -$35.19M 10-Q · filed 2021-11-09 | -$46.19M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$11.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$23.33M 10-Q · filed 2021-08-05 | -$34.33M derived: sum of 3 quarters · filed 2022-02-28 | -$45.47M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$12.11M 10-Q · filed 2021-05-06 | -$23.11M derived: sum of 2 quarters · filed 2022-02-28 | -$34.25M derived: sum of 3 quarters · filed 2022-02-28 | -$45.29M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$22.14M derived: sum of 2 quarters · filed 2022-02-28 | -$33.18M derived: sum of 3 quarters · filed 2022-02-28 | -$46.41M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$11.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$22.18M derived: sum of 2 quarters · filed 2020-11-05 | -$35.41M 10-Q · filed 2020-11-05 | -$50.84M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$11.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$24.27M 10-Q · filed 2020-08-06 | -$39.70M derived: sum of 3 quarters · filed 2021-03-29 | -$54.09M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$13.23M 10-Q · filed 2020-05-06 | -$28.66M derived: sum of 2 quarters · filed 2021-03-29 | -$43.05M derived: sum of 3 quarters · filed 2021-03-29 | -$60.45M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$15.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$29.82M derived: sum of 2 quarters · filed 2021-03-29 | -$47.21M derived: sum of 3 quarters · filed 2021-03-29 | -$75.23M 10-K · filed 2021-03-29 |
| 2018-09-30 | -$14.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$31.78M derived: sum of 2 quarters · filed 2019-11-12 | -$59.80M 10-Q · filed 2019-11-12 | -$79.33M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | -$17.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$45.42M 10-Q · filed 2019-08-07 | -$64.94M derived: sum of 3 quarters · filed 2020-03-26 | -$89.30M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$28.02M 10-Q · filed 2019-05-07 | -$47.54M derived: sum of 2 quarters · filed 2020-03-26 | -$71.90M derived: sum of 3 quarters · filed 2020-03-26 | -$92.69M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$19.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$43.88M derived: sum of 2 quarters · filed 2020-03-26 | -$64.67M derived: sum of 3 quarters · filed 2020-03-26 | -$99.93M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$24.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$45.15M derived: sum of 2 quarters · filed 2018-11-07 | -$80.41M 10-Q · filed 2018-11-07 | -$100.76M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$20.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$56.05M 10-Q · filed 2018-08-08 | -$76.40M derived: sum of 3 quarters · filed 2019-03-07 | -$100.35M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$35.26M 10-Q · filed 2018-05-10 | -$55.61M derived: sum of 2 quarters · filed 2019-03-07 | -$79.57M derived: sum of 3 quarters · filed 2019-03-07 | |
| 2016-12-31 | -$20.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$44.30M derived: sum of 2 quarters · filed 2019-03-07 | -$113.04M 10-K · filed 2019-03-07 | |
| 2016-09-30 | -$23.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$92.69M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$68.73M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | -$98.89M 10-K · filed 2018-03-07 | |||
| 2011-06-30 | -$18.23M 10-Q · filed 2011-08-04 | |||
| 2010-06-30 | -$16.61M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |